171 related articles for article (PubMed ID: 31904355)
1. Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration.
Cobo-Vuilleumier N; Gauthier BR
Metabolism; 2020 Mar; 104():154137. PubMed ID: 31904355
[TBL] [Abstract][Full Text] [Related]
2. Targeting LRH-1/NR5A2 to treat type 1 diabetes mellitus.
Cobo-Vuilleumier N; Lorenzo PI; Gauthier BR
Cell Stress; 2018 May; 2(6):141-143. PubMed ID: 31225479
[TBL] [Abstract][Full Text] [Related]
3. Original hypothesis: Extracorporeal shockwaves as a homeostatic autoimmune restorative treatment (HART) for Type 1 diabetes mellitus.
Craig K; d'Agostino C; Poratt D; Walker M
Med Hypotheses; 2014 Sep; 83(3):250-3. PubMed ID: 24947195
[TBL] [Abstract][Full Text] [Related]
4. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.
Cobo-Vuilleumier N; Lorenzo PI; Rodríguez NG; Herrera Gómez IG; Fuente-Martin E; López-Noriega L; Mellado-Gil JM; Romero-Zerbo SY; Baquié M; Lachaud CC; Stifter K; Perdomo G; Bugliani M; De Tata V; Bosco D; Parnaud G; Pozo D; Hmadcha A; Florido JP; Toscano MG; de Haan P; Schoonjans K; Sánchez Palazón L; Marchetti P; Schirmbeck R; Martín-Montalvo A; Meda P; Soria B; Bermúdez-Silva FJ; St-Onge L; Gauthier BR
Nat Commun; 2018 Apr; 9(1):1488. PubMed ID: 29662071
[TBL] [Abstract][Full Text] [Related]
5. Islet Microencapsulation: Strategies and Clinical Status in Diabetes.
Omami M; McGarrigle JJ; Reedy M; Isa D; Ghani S; Marchese E; Bochenek MA; Longi M; Xing Y; Joshi I; Wang Y; Oberholzer J
Curr Diab Rep; 2017 Jul; 17(7):47. PubMed ID: 28523592
[TBL] [Abstract][Full Text] [Related]
6. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
[TBL] [Abstract][Full Text] [Related]
8. Approaches for the cure of type 1 diabetes by cellular and gene therapy.
Jun HS; Yoon JW
Curr Gene Ther; 2005 Apr; 5(2):249-62. PubMed ID: 15853732
[TBL] [Abstract][Full Text] [Related]
9. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration.
Couri CE; Foss MC; Voltarelli JC
Braz J Med Biol Res; 2006 Oct; 39(10):1271-80. PubMed ID: 16941054
[TBL] [Abstract][Full Text] [Related]
10. Prospects for gene therapy of insulin-dependent diabetes mellitus.
Efrat S
Diabetologia; 1998 Dec; 41(12):1401-9. PubMed ID: 9867206
[TBL] [Abstract][Full Text] [Related]
11. Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes.
von Herrath M; Homann D
Pediatr Diabetes; 2004; 5 Suppl 2():23-8. PubMed ID: 15601371
[TBL] [Abstract][Full Text] [Related]
12. Engineering β-cell islets or islet-like structures for type 1 diabetes treatment.
Liu X; Li X; Zhang N; Wen X
Med Hypotheses; 2015 Jul; 85(1):82-4. PubMed ID: 25892491
[TBL] [Abstract][Full Text] [Related]
13. β-Cell differentiation and regeneration in type 1 diabetes.
Ding L; Gysemans C; Mathieu C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():98-104. PubMed ID: 24003926
[TBL] [Abstract][Full Text] [Related]
14. Islet replacement vs. regeneration: hope or hype?
Ramiya V; Schatz D
Pediatr Diabetes; 2004; 5 Suppl 2():45-56. PubMed ID: 15601374
[TBL] [Abstract][Full Text] [Related]
15. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
Dotta F; Eisenbarth GS
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
[TBL] [Abstract][Full Text] [Related]
16. Regeneration therapy of pancreatic beta cells: towards a cure for diabetes?
Yamaoka T
Biochem Biophys Res Commun; 2002 Sep; 296(5):1039-43. PubMed ID: 12207876
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.
Eizirik DL; Colli ML; Ortis F
Nat Rev Endocrinol; 2009 Apr; 5(4):219-26. PubMed ID: 19352320
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus.
Hou WR; Xie SN; Wang HJ; Su YY; Lu JL; Li LL; Zhang SS; Xiang M
Pharmacol Res; 2011 Apr; 63(4):320-7. PubMed ID: 21185938
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes.
Tanaka S; Aida K; Nishida Y; Kobayashi T
Endocr J; 2013; 60(7):837-45. PubMed ID: 23774118
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of the pancreatic beta cell.
Trucco M
J Clin Invest; 2005 Jan; 115(1):5-12. PubMed ID: 15630433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
